Učitavanje...
Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy
The heterogeneity of tumor is considered as a major difficulty to victorious personalized cancer medicine. There is an extremeneed of consistent response evaluation for in vivo tumor heterogeneity anditscoupledconflict mechanisms. In this occasion researchers will be able to keep pace withpredictive...
Spremljeno u:
| Izdano u: | J Diabetes Metab Disord |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6154523/ https://ncbi.nlm.nih.gov/pubmed/30288382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40200-018-0334-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|